Cláudio Tadeu Daniel-Ribeiro Selected Research

Chloroquine (Aralen)

1/2024	Are pvcrt-o and pvmdr1 Gene Mutations Associated with Plasmodium vivax Chloroquine-Resistant Parasites?
1/2024	Relapsing Plasmodium vivax malaria in a 12-year-old Brazilian girl: A case report.
10/2023	A fatal respiratory complication of malaria caused by Plasmodium vivax.
1/2022	Dynamics and immunomodulation of cognitive deficits and behavioral changes in non-severe experimental malaria.
8/2021	Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases.
1/2020	Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes.
2/2019	Lack of quadruple and quintuple mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates from Brazilian endemic areas.
1/2019	Chloroquine and mefloquine resistance profiles are not related to the circumsporozoite protein (CSP) VK210 subtypes in field isolates of Plasmodium vivax from Manaus, Brazilian Amazon.
1/2018	Long-term effect of uncomplicated Plasmodium berghei ANKA malaria on memory and anxiety-like behaviour in C57BL/6 mice.
9/2017	Synthesis, antimalarial activity in vitro, and docking studies of novel neolignan derivatives.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cláudio Tadeu Daniel-Ribeiro Research Topics

Disease

34	Malaria 07/2023 - 02/2005
20	Infections 06/2023 - 02/2004
10	Vivax Malaria 04/2024 - 04/2008
5	Cerebral Malaria 01/2023 - 08/2014
4	Anemia 01/2021 - 04/2008
3	Falciparum Malaria (Plasmodium falciparum Malaria) 05/2023 - 01/2017
3	COVID-19 01/2022 - 01/2020
3	Parasitemia 01/2019 - 08/2011
2	Tetanus 01/2023 - 01/2022
2	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2020
2	Diphtheria 01/2023 - 01/2022
2	Acute malaria 09/2013 - 06/2007
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2023
1	Neuroinflammatory Diseases 01/2023
1	Post-Acute COVID-19 Syndrome 01/2022
1	Reinfection 01/2022
1	Coma (Comas) 01/2021
1	Bites and Stings (Sting) 01/2021
1	Hypoxia (Hypoxemia) 01/2019
1	Ischemia 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Thrombosis (Thrombus) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 09/2017
1	Dengue (Dengue Fever) 03/2016
1	Hyperplasia 03/2015
1	Convalescence 03/2015
1	Acute Disease 03/2015
1	Toxoplasmosis 11/2013
1	Asymptomatic Infections 09/2013
1	Autoimmune Diseases (Autoimmune Disease) 08/2011
1	Necrosis 08/2011

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 02/2023 - 02/2005
12	Chloroquine (Aralen)FDA LinkGeneric 01/2024 - 11/2009
10	AntibodiesIBA 02/2023 - 04/2008
9	AntigensIBA 06/2023 - 04/2010
5	Immunoglobulin G (IgG)IBA 07/2023 - 09/2013
4	Primaquine FDA Link 01/2024 - 02/2004
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2011
4	Antimalarials (Antimalarial Agents)IBA 01/2022 - 12/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 08/2014
3	Immunoglobulin M (IgM)IBA 07/2023 - 11/2013
3	Mefloquine (Lariam)FDA LinkGeneric 01/2019 - 11/2009
3	CytokinesIBA 04/2015 - 04/2008
3	Interleukin-10 (Interleukin 10)IBA 03/2015 - 04/2008
2	Artemether FDA Link 01/2023 - 01/2021
2	Malaria VaccinesIBA 01/2022 - 04/2010
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019 - 06/2007
2	Interleukin-12 (IL 12)IBA 03/2015 - 04/2008
2	Glutamic Acid (Glutamate)FDA Link 06/2013 - 08/2011
1	Peptide Hydrolases (Proteases)FDA Link 04/2024
1	18S Ribosomal RNAIBA 06/2023
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 02/2023
1	Antiparasitic Agents (Antiparasitics)IBA 04/2022
1	Inactivated VaccinesIBA 01/2022
1	Diphtheria-Tetanus VaccineIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 10/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 06/2020
1	Folic Acid AntagonistsIBA 02/2019
1	Arginine (L-Arginine)FDA Link 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	CaspasesIBA 01/2019
1	CalciumIBA 01/2019
1	ArtesunateIBA 01/2019
1	ThromboxanesIBA 01/2019
1	Protein Subunit VaccinesIBA 11/2017
1	Peptides (Polypeptides)IBA 11/2017
1	LignansIBA 09/2017
1	HypoxanthineIBA 09/2017
1	Liposomes (Liposome)IBA 01/2017
1	Clodronic Acid (Clodronate)IBA 01/2017
1	ElectrolytesIBA 03/2016
1	hemozoinIBA 03/2015
1	Interleukin-2 (IL2)IBA 03/2015
1	Interleukin-6 (Interleukin 6)IBA 03/2015
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 09/2013
1	pyrimethamine drug combination fanasil (Fansidar)FDA Link 08/2011
1	5- aminocarbonyl- 10,11- dihydro- 5H- dibenzo(a,d)cyclohepten- 5,10- imine (ADCI)IBA 08/2011
1	artemisinin (artemisinine)IBA 11/2009
1	Quinine (Quinson)FDA Link 11/2009
1	AutoantibodiesIBA 04/2008
1	ChemokinesIBA 04/2008
1	Cardiolipins (Cardiolipin)IBA 04/2008
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2008
1	Interferon-gamma (Interferon, gamma)IBA 04/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008

Therapy/Procedure

6	Therapeutics 05/2023 - 08/2011
3	Blood Transfusion (Blood Transfusions) 01/2023 - 10/2017
3	Immunomodulation 01/2023 - 01/2022
1	Hand Hygiene 01/2020
1	Organ Transplantation 10/2017
1	Drug Therapy (Chemotherapy) 09/2017
1	Splenectomy 01/2017
1	Aftercare (After-Treatment) 03/2015
1	Chemoprevention 05/2011
1	Contraindications 02/2004